Genitourinary Drugs Market Size, Trends and Growth Analysis By Disease (Urinary Tract Infections, Erectile Dysfunction, Hematuria), Product (Urological, Hormonal Therapy, and Others), Key Players and Region, Forecast to 2023
Genitourinary Drugs Market size will grow at a CAGR of 1.65% over the forecast period 2018 to 2023. Genitourinary disorders are caused by damage to the urinary tract or genital organs. Genitourinary drugs are used for the treatment of medical complications related to the kidney, bladder, ureter and urethra. The increasing cases of genitourinary disorders, surge in number of people suffering from cancer, increasing prevalence of sexually transmitted diseases, and rise in number of drugs in pipeline are the major factors driving the growth of the global genitourinary drugs market.
According to the Centers for Disease Control and Prevention (CDC), more than 2.3 million Americans were diagnosed with sexually transmitted diseases in year 2017, Most common sexually transmitted diseases in American region are chlamydia, gonorrhea, and syphilis. Moreover, increase in strategic collaborations and aggressive strategy adopted by major players in the market is also responsible for the growth of the market.
The increasing appearance of drug counterfeiting in pharmaceutical industry, intense competition from generic manufacturers and drug patent expirations are likely to hinder market growth during the forecast period.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/6802
Genitourinary Drugs Market Segmentation:
The global genitourinary drugs market is segmented based on disease, product, and end-user.
By disease, the genitourinary drugs market is classified as urinary tract infections, erectile dysfunction, urinary incontinence & overactive bladder, kidney/renal cancer, genitourinary cancer, bladder cancer, bladder cancer, cervical cancer, sexually transmitted diseases, interstitial cystitis, hematuria, ovarian cancer, and prostate cancer.
By product, the genitourinary drugs market is segregated into urological, hormonal therapy, gynecological, and anti-infectives.
By end-user, the genitourinary drugs market segment is divided into, hospitals, clinics, super specialty centers, and others.
Genitourinary Drugs Market Key Players
Some of the key players in the global genitourinary drugs market are Bayer AG, Astra Zeneca, Abbott, Astellas Pharma Inc., Pfizer Inc., Eli Lilly and Company, Genentech, Inc., Immunex Corp. GlaxoSmithKline plc., Ionis Pharmaceuticals, Inc., Merck & Co., Bristol-Myers Squibb Company, Antares Pharma and Novartis AG
Genitourinary Drugs Market Regional Analysis
The Americas is expected to dominate the global genitourinary drugs market during the forecast period owing to the rising prevalence of genitourinary disorders, increasing cancer patients in the region, rise in healthcare expenditure, and the presence of a well-established healthcare system. The European market is expected to be the second-largest due to the government initiatives for the development of healthcare sector, increasing research and development activities in the region and rise in number of chronic disorders.
Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing geriatric population, rising investments in healthcare sector and favorable government policies. The market in the Middle East & Africa is likely to account for the smallest share of the global genitourinary drugs market. The market growth in this region can be attributed to increasing healthcare expenditure and growing medical tourism.
Browse Full Report Details at: https://www.marketresearchfuture.com/reports/genitourinary-drugs-market-6802
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future